Methylfolate vs folic acid: the 40% conversion problem

Your multivitamin contains folic acid. Your prenatal contains folic acid. The cereal your kids eat for breakfast is fortified with folic acid. And for roughly 40% of the people taking it, the body is sitting there holding a key that doesn’t fit the lock.

Folic acid is a synthetic precursor to folate. It only works if your liver can convert it. And there’s a common genetic variant that makes that conversion slow, inefficient, or both.

This is the gap between “the cheapest form the FDA approved in 1998” and “the form your cells actually use.” Most supplement brands pick the first one. Here’s what that decision costs you.

Folate, folic acid, and methylfolate are not the same thing

Folate is the umbrella term for a B-vitamin that shows up in green leafy vegetables, legumes, and liver. Your body uses it for DNA synthesis, red blood cell formation, homocysteine regulation, and neurotransmitter production.

Folic acid is the synthetic oxidised version used in supplements and mandatory food fortification. It does not exist in food. It was chosen because it is cheap, stable, and easy to manufacture.

L-5-methyltetrahydrofolate (methylfolate, L-methylfolate, or L-5-MTHF) is the active circulating form. It’s what folic acid eventually becomes after your body processes it through a multi-step enzymatic pathway. Skip the processing, skip the bottleneck.

The MTHFR problem most labels don’t mention

For folic acid to become usable methylfolate, it has to pass through an enzyme called methylenetetrahydrofolate reductase (MTHFR). Two common variants of the gene that codes for this enzyme reduce its activity.

The C677T variant is the best studied. Roughly 30-40% of the general population is heterozygous (one copy) and around 10% is homozygous (two copies), with higher rates in some Mediterranean and Hispanic populations (Moll & Varga, Circulation, 2015). Homozygotes show roughly 70% reduced enzyme activity. Heterozygotes sit around 30-40% reduced activity.

Add up the carriers and you land at about 40% of people working with a compromised conversion pathway. That’s the headline number. It doesn’t mean those people can’t process folate at all. It means they process folic acid slower than the label assumes.

What happens when folic acid goes unconverted

When intake exceeds conversion capacity, unmetabolised folic acid (UMFA) shows up in the bloodstream. Research in Nutrients has documented UMFA circulating in adults after doses as low as 200-400mcg, the range found in most daily supplements and fortified foods.

The clinical significance of UMFA is still being debated. Some studies associate chronically elevated UMFA with altered immune function and potential interference with B12 status assessment. Research suggests avoiding high-dose folic acid when an active form is available, particularly in populations with MTHFR variants.

Meanwhile methylfolate bypasses the conversion step entirely. A 2010 pharmacokinetic review in Clinical Pharmacokinetics found L-5-MTHF produced equivalent or superior plasma folate responses compared to folic acid across multiple trials, without the UMFA accumulation (Pietrzik, Bailey & Shane, Clin Pharmacokinet, 2010;49(8):535-48).

The short version. If your body converts folic acid well, methylfolate works. If your body converts folic acid poorly, methylfolate still works. It’s the form that’s agnostic to your genetics.

Why the supplement industry keeps using folic acid anyway

Folic acid is cheaper. Roughly 5-10x cheaper per gram than pharmaceutical-grade methylfolate (Metafolin or Quatrefolic). For a brand filling a capsule or tablet with 400mcg, the difference is a few cents per bottle. Across a production run, the margin difference matters more to the formulator than the 40% of customers with compromised conversion.

Folic acid is also more stable in tablet form. Methylfolate is more sensitive to light, heat, and moisture. Using it properly requires encapsulation in a form that protects it from oxidation. More cost. More process. More reasons to default to folic acid on the label.

And then there’s inertia. The US mandate to fortify grain products with folic acid went into effect in 1998 to reduce neural tube defects. Fortification worked. That success calcified an assumption that “folic acid is the folate” in regulatory and formulation thinking. Two decades later, that assumption still drives most supplement labels.

What to look for on a label

Ignore the word “folate” on the front of the bottle. Flip to the supplement facts panel and check the parenthetical after the dose.

• “Folic acid” = synthetic, requires conversion, pixie-dust for MTHFR variants
• “Folate (as folic acid)” = same as above, dressed up
• “L-5-methyltetrahydrofolate” / “L-methylfolate” / “methylfolate” / “Metafolin” / “Quatrefolic” = active form, bypasses the conversion
• “Folinic acid” = a different active metabolite, generally acceptable, less studied at maintenance doses

If the label just says “folic acid,” you know what you’re getting. If it says “folate” without a parenthetical, ask the brand directly. The good brands will tell you. The ones that don’t answer have usually answered by not answering.

What Fireblood does

Fireblood contains 667ug DFE of folate as L-5 Methyltetrahydrofolate. That’s the active form, ready to use, regardless of whether your MTHFR genes are cooperating. No conversion step. No bet on whether your liver enzymes are running at full speed.

We chose it because it costs more and it works for everyone. The same logic applies to every other vitamin form in the formula. Methylcobalamin instead of cyanocobalamin for B12. P5P instead of pyridoxine for B6. Riboflavin 5-phosphate instead of riboflavin for B2. D3 instead of D2. MK-4 instead of MK-7 for vitamin K2.

The label shows every form and every dose. That transparency is the whole point. You shouldn’t have to send a genetic test to know whether your daily supplement is actually working.

Fireblood delivers 667ug DFE of folate as active L-5-methyltetrahydrofolate, alongside 38 other nutrients in their bioavailable forms. No proprietary blends. No synthetic shortcuts. See the full formula and choose your path here.

References

• Moll S, Varga EA. Homocysteine and MTHFR Mutations. Circulation. 2015;132(1):e6-e9. PubMed
• Obeid R, Herrmann W. The emerging role of unmetabolized folic acid in human diseases: myth or reality? Current Drug Metabolism. Various reviews 2012-2019 on UMFA circulation and health implications.
• Pietrzik K, Bailey L, Shane B. Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2010;49(8):535-48. PubMed
• NIH Office of Dietary Supplements. Folate Fact Sheet for Health Professionals. ods.od.nih.gov